EyePoint Plc (EYPT)
13.04
-0.01
(-0.08%)
USD |
NASDAQ |
Mar 26, 12:24
EyePoint Free Cash Flow : -243.39M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ocular Therapeutix, Inc. | -216.89M |
| Regeneron Pharmaceuticals, Inc. | 3.765B |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Vertex Pharmaceuticals, Inc. | 3.194B |
| Cellectar Biosciences, Inc. | -23.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -65.05M |
| Cash from Investing (Quarterly) | -74.67M |
| Cash from Financing (Quarterly) | 166.96M |
| Free Cash Flow Per Share (Quarterly) | -0.7953 |
| Free Cash Flow to Equity (Quarterly) | -65.56M |
| Free Cash Flow to Firm (Quarterly) | -66.03M |
| Free Cash Flow Yield | -25.49% |